Design Therapeutics Inc
NASDAQ:DSGN
Design Therapeutics Inc
NASDAQ:DSGN
Price:
4.47 USD
1.36%
Updated:
May 20, 2024
Design Therapeutics Inc
Other Non-Cash Items
|
Design Therapeutics Inc
Other Non-Cash Items Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Design Therapeutics Inc
NASDAQ:DSGN
|
Other Non-Cash Items
$7m
|
CAGR 3-Years
156%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Non-Cash Items
$7.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
29%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Non-Cash Items
$8.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
35%
|
CAGR 10-Years
37%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Non-Cash Items
$1.8B
|
CAGR 3-Years
157%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Non-Cash Items
$585.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
110%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is Design Therapeutics Inc's Other Non-Cash Items?
Other Non-Cash Items
7m
USD
7m
USD
Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Other Non-Cash Items amounts to 7m USD.
What is Design Therapeutics Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 3Y
156%
156%
Over the last year, the Other Non-Cash Items growth was -26%. The average annual Other Non-Cash Items growth rates for Design Therapeutics Inc have been 156% over the past three years .
You don't have any saved screeners yet
